Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk for Breast Cancer”

348 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 348 results

Not applicableStudy completedNCT03729661
What this trial is testing

Exploratory Study on Therapy for Breath Hold in Radiotherapy

Who this might be right for
Lung CancerBreast Cancer
Maastricht Radiation Oncology 20
Not applicableStudy completedNCT03856372
What this trial is testing

Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 1,494
Not applicableStudy completedNCT01508273
What this trial is testing

Lifestyle Intervention for High Risk Cancer Survivors

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 1,150
Testing effectiveness (Phase 2)WithdrawnNCT03384095
What this trial is testing

Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias

Who this might be right for
Breast Neoplasm FemaleArthralgia
Erin Newton
Early research (Phase 1)Active Not RecruitingNCT03589339
What this trial is testing

NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

Who this might be right for
RadiotherapyImmunotherapyMicrosatellite Instability-High Solid Malignant Tumour+8 more
Nanobiotix 145
Testing effectiveness (Phase 2)UnknownNCT05556200
What this trial is testing

A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILs

Who this might be right for
Breast CancerTriple-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 58
Not applicableEnded earlyNCT03560102
What this trial is testing

Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer

Who this might be right for
Breast Cancer, Invasive Ductal
Kantonsspital Winterthur KSW 1
Not applicableStudy completedNCT04378751
What this trial is testing

Promoting Genetic Counseling Among African American Women With a Family History of Breast Cancer

Who this might be right for
High Risk for Breast Cancer
University of Illinois at Chicago 80
Testing effectiveness (Phase 2)UnknownNCT00080756
What this trial is testing

Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer
City of Hope Medical Center 11
Not applicableStudy completedNCT05797129
What this trial is testing

CEDM as a Screening Tool for Breast Cancer in Higher-risk Women: A Prospective Study

Who this might be right for
Breast Cancer
Kaohsiung Veterans General Hospital. 351
Not applicableUnknownNCT03617341
What this trial is testing

Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer With HER2 PositiveTriple Negative Breast Cancer
Yonsei University 200
Large-scale testing (Phase 3)Study completedNCT01547741
What this trial is testing

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 4,242
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07492121
What this trial is testing

Screening for Brain Metastases

Who this might be right for
Lung Cancer Stage IVMelanoma Stage IVBreast Cancer Metastatic
University of Zurich 180
Early research (Phase 1)WithdrawnNCT06982222
What this trial is testing

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+4 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00407888
What this trial is testing

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-positive Breast CancerStage IA Breast Cancer+6 more
University of Washington 60
Not applicableActive Not RecruitingNCT02494869
What this trial is testing

Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer

Who this might be right for
High Risk for Developing Breast Cancer
Memorial Sloan Kettering Cancer Center 75
Post-approval studies (Phase 4)Looking for participantsNCT04790305
What this trial is testing

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

Who this might be right for
Carcinoma BreastTriple-negative Breast CancerInvasive Ductal Carcinoma, Breast
Fudan University 1,072
Not applicableLooking for participantsNCT06629896
What this trial is testing

Contrast Enhancement Mammography vs MRI for the Surveillance of Women at High Risk of Breast Cancer: Con-trust Randomized Controlled Trial

Who this might be right for
Breast Cancer Screening and Diagnosis
Azienda USL Reggio Emilia - IRCCS 2,200
Large-scale testing (Phase 3)Study completedNCT00129389
What this trial is testing

FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 1,925
Not applicableUnknownNCT03383835
What this trial is testing

Study of Moderate Dose Omega 3 Fatty Acid Supplement in Premenopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast Cancer
Lauren Nye 11
Next Page